Psychotherapy for Borderline Personality Disorder: Does the Type of Treatment Make a Difference? by Ellison, William D
Trinity University 
Digital Commons @ Trinity 
Psychology Faculty Research Psychology Department 
9-2020 
Psychotherapy for Borderline Personality Disorder: Does the Type 
of Treatment Make a Difference? 
William D. Ellison 
Trinity University, wellison@trinity.edu 
Follow this and additional works at: https://digitalcommons.trinity.edu/psych_faculty 
 Part of the Psychology Commons 
Publication Details 
Current Treatment Options in Psychiatry 
Repository Citation 
Ellison, W. D. (2020). Psychotherapy for borderline personality disorder: Does the type of treatment make 
a difference?. Current Treatment Options in Psychiatry, 7(3), 416-428. doi: 10.1007/s40501-020-00224-w 
This Post-Print is brought to you for free and open access by the Psychology Department at Digital Commons @ 
Trinity. It has been accepted for inclusion in Psychology Faculty Research by an authorized administrator of Digital 
Commons @ Trinity. For more information, please contact jcostanz@trinity.edu. 
 
 
 
 
Psychotherapy for Borderline Personality Disorder: Does the Type of Treatment Make a 
Difference? 
 
William D. Ellison, Ph.D. 
Trinity University 
ORCiD: https://orcid.org/0000-0002-3354-7366 
 
This is a post-peer-review, pre-copyedit version of an article published in Current Treatment 
Options in Psychiatry. The final authenticated version is available online at: 
http://dx.doi.org/10.1007/s40501-020-00224-w 
 
Corresponding Author: William D. Ellison, Department of Psychology, Trinity University, One 
Trinity Place, San Antonio, TX, USA 78212. E-mail: wellison@trinity.edu.  
Keywords: Borderline Personality Disorder; Psychotherapy; Dialectical Behavior Therapy; 
Mentalization-Based Treatment; Schema Therapy; Transference-Focused Psychotherapy  
Abstract 
Purpose of Review: The first aim of this review is to summarize the major evidence-based 
psychotherapies for Borderline Personality Disorder (BPD) and the research supporting their use. 
The second aim is to explore the evidence for the differential effectiveness of these treatments. 
Recent Findings: Four types of specific psychotherapies are identified that show promising 
results in at least two randomized controlled trials. In addition, several adjunctive and 
minimal/pragmatic interventions are available that are supported by research evidence. Recent 
findings highlight the applicability of these treatments across settings and populations and have 
begun to show that modified versions of them are also beneficial. 
Summary: There is solid evidence that various specific therapies are superior to treatment as 
usual in the community for Borderline Personality Disorder. There is no reliable evidence that 
any of these specific treatments is more effective than any other, however. In addition, existing 
treatments have many elements in common that may be responsible in part for their effects. 
Future research will be needed to uncover the influence of various study design factors, patient 
characteristics, and treatment parameters on psychotherapy outcome for BPD.  
 
  
Introduction 
 Borderline Personality Disorder (BPD) is a relatively severe, impairing, and costly form 
of mental illness. [1–3] Studies estimate its prevalence at around 1-2% of the general adult 
population and 10-12% of psychiatric outpatients, and the disorder is notably common among 
individuals presenting for medical care in other settings. [4] BPD is also probably 
underdiagnosed, or misdiagnosed as other disorders, and there remains some degree of stigma 
towards individuals with the disorder and pessimism about the prospect of successful treatment 
among clinicians, although this situation may be improving. [5–9] 
Nonetheless, abundant research now demonstrates the efficacy and effectiveness of 
several kinds of psychotherapies for BPD. A recent meta-analysis of randomized controlled trials 
suggested small to moderate effect sizes differentiating BPD-specific treatments from treatment 
as usual in terms of symptom reduction and amelioration of functioning. [10••] Both Dialectical 
Behavior Therapy and specialized psychodynamic psychotherapies were superior to control 
groups in this review. There remained a high degree of heterogeneity between the included 
studies’ effect sizes, however, showing that the research picture is complicated by other 
differences among these trials. Nevertheless, there exists a remarkably diverse array of evidence-
based psychotherapies for BPD as compared with many other forms of psychopathology. These 
treatments vary in several respects: they come from different theoretical backgrounds and follow 
different assumptions as to the core nature of BPD itself; they target different symptoms and use 
different techniques; and they are designed with different structures and sometimes for different 
settings. Thus, an array of different empirically-supported treatment options is available for this 
disorder, despite lingering therapeutic pessimism. 
The purpose of this review is to summarize the available evidence-based psychotherapies 
for BPD and to highlight major research findings that might serve as guidance for clinicians who 
are considering training in one of these modalities or considering referring patients with BPD for 
specialty care. I will also emphasize commonalities and differences among the various 
treatments. Finally, I will address whether the type of treatment makes a difference in terms of 
outcome for the average patient. 
Stand-Alone, Specialty Treatments for BPD 
 The most prominent and widespread evidence-based treatments for BPD were developed 
specifically to treat individuals with the disorder. They were spurred by a recognition on the part 
of their developers that existing therapies were inadequate for patients with BPD, did not focus 
on core symptoms, or used techniques that were unhelpful for this population. Four major stand-
alone, specialty treatments have been developed that have shown positive results in at least two 
randomized controlled trials (RCT’s). 
Dialectical Behavior Therapy (DBT). Originally developed by Marsha Linehan, DBT is 
based on her “biosocial” account of the development of BPD, which holds that the disorder 
stems from a combination of a biological tendency to emotional extremes and an invalidating 
early environment, producing maladaptive emotion regulation strategies, such as deliberate self-
harm. [11] The treatment itself makes use of a broad suite of cognitive, behavioral, and problem-
solving interventions, including skills training and in-session coaching, chain analysis, 
contingency management, and exposure. These interventions are paired with mindfulness and 
other practices from Zen Buddhism, with the ultimate aim of decoupling extreme emotional 
experiences from maladaptive behavioral responses. [12] DBT also attends closely to client 
motivation as a way to foster engagement in treatment and prevent dropout. The “dialectic” in 
the treatment is the back-and-forth between validation – an acceptance of the individual’s 
struggles as genuine and understandable – and the need for change; the therapist’s focus on this 
dialectic is meant to enhance the patient’s engagement in treatment and prevent dropout. 
Traditional DBT includes both individual sessions and group-based skills training modules 
focused on mindfulness, interpersonal effectiveness, distress tolerance, and emotion regulation. 
[13]  
Among the major treatments for BPD, DBT is undoubtedly the therapy with the broadest 
evidence base. Since the pioneering randomized controlled trial by Linehan, [14] several 
prominent RCT’s of standard outpatient DBT have accumulated. [13,15,16]  Adaptations for 
inpatient and partial-hospital settings and college counseling centers have also been developed. 
[17–20] More recently, a randomized trial investigated whether the major treatment components 
of DBT – individual DBT and group-based DBT skills training – are any less effective on their 
own than the full DBT package. Results did not support the notion that the combination of 
individual DBT and group skills training is necessary. [13] The finding that skills group is 
effective on its own is consistent with prior research suggesting that increased skills use can 
mediate many of the most important reductions in symptoms that DBT produces, and trials of 
DBT skills groups without individual therapy have also resulted in encouraging outcomes. [21–
24] Likewise, the symptom reduction in the individual-only DBT group in this trial is consistent 
with a small study showing no differences between individual DBT and individual DBT plus 
skills training. [25] 
Mentalization-Based Treatment (MBT). MBT is premised on a developmental model of 
BPD that is focused on mentalization – the process of understanding one’s own, and others’, 
actions in terms of mental states (such as beliefs and intentions). [26] The capacity to mentalize 
is thought to develop within the attachment system and to be impaired in individuals with BPD, 
resulting in dysfunctional relatedness, self-harm, impulsivity, and the other hallmarks of the 
disorder. [27] Accordingly, MBT therapists seek to enhance a patient’s capacity to mentalize, as 
well as to identify their affective experience and connect this with how these affects are 
represented mentally. The ultimate goal of the treatment is to move the patient toward secure 
attachment, thereby enabling effective relationships and better affect and behavior 
regulation.[28] 
 Evidence for the efficacy of MBT comes from several RCT’s. The first of these showed 
the superiority of 18 months of MBT delivered in a partial-hospital setting to treatment as usual, 
with very large between-group effects. [29] Notably, these gains were maintained at 18-month 
and 5-year follow-up, although patients were still underemployed and functioning at a relatively 
low level at the last assessment. [30,31] The second of these investigated an outpatient version of 
this treatment, with similarly promising results relative to community treatment. [32] A third 
RCT suggested that MBT produced similar gains in clinical outcomes to DBT. [33] Tests of 
MBT’s effectiveness in ordinary practice settings are also positive. [34,35] Nevertheless, other 
results have been somewhat less encouraging; a randomized, partly controlled study of MBT 
compared with supportive psychotherapy showed similar outcomes between treatments on all but 
one primary outcome measure, [36] and another recent RCT suggested no difference in outcome 
between MBT and “specialist treatment as usual.” [37] Differences in treatment intensity 
between day-hospital MBT and outpatient MBT may not account for any discrepancies in 
efficacy – a recent RCT suggested that these two forms of the treatment produce similar 
outcomes. [38] Further research will be needed to clarify what factors influence the success of 
MBT, as well as to explicate its mechanisms of action. 
Schema Therapy (ST). Originally known as Schema-Focused Therapy, this treatment was 
developed by Jeffrey Young as a form of cognitive therapy. ST sees BPD as stemming from a 
characteristic set of stereotypical “schema modes,” or patterns of thinking, feeling, and behaving 
with early developmental roots. BPD is thought to involve four or five of these modes, including 
the Angry and Impulsive Child, the Abused and Abandoned Child, the Detached Protector, the 
Punitive Parent, and (sometimes) the Healthy Adult. [39–41] The patient shifts abruptly among 
these different schemas, leading to the chaotic clinical picture. ST therapist’s aim is to facilitate 
the substitution of these maladaptive schemas with healthier ones, between which the individual 
can shift gradually based on the realistic demands of his or her environment. To this end, ST 
utilizes cognitive, experiential, and behavioral interventions and focuses heavily on the provision 
of a strong, quasi-parental relationship between patient and therapist. [39] 
ST has shown efficacy in one RCT comparing three years of ST to three years of 
Transference-Focused Psychotherapy (TFP; see below). The ST group had less dropout and 
better clinical outcomes than the TFP group. [42] Other randomized trials have examined group-
based ST in comparison to treatment as usual and have suggested that therapist after-hours 
telephone availability is not necessary for improvement in ST. [43,44] More recently, outcome 
studies have examined combinations of individual and group ST [45] and community 
implementations of ST. [46] 
Transference-Focused Psychotherapy (TFP). TFP is based on the modified 
psychoanalytic treatment framework by Otto Kernberg, which in turn is based on Kernberg’s 
seminal description of borderline personality.[47] Like ST, TFP is organized around the theory 
that the core deficit in BPD is the individual’s disordered and incoherent mental representations 
of self and others. These representations are thought to be “split,” or organized into all-positive 
and all-negative parts, which makes it difficult for the patient to regulate their emotions and 
behaviors effectively, especially in an interpersonal context. [48] A TFP therapist intervenes to 
modify these representations, chiefly by using events in the therapeutic relationship to observe 
and explore them, to point out conflicting elements of the patient’s views of self or others, and to 
suggest alternative, more realistic views. Thus, unlike classical psychoanalysis, TFP restricts 
attention to the “here-and-now,” and the therapist takes a very active stance. Like DBT, TFP 
proceeds within a strong treatment frame, with a clear delineation of patient and therapist 
responsibilities; patients are required to pursue meaningful activity (e.g., employment), to 
maintain sobriety, and to participate fully in treatment sessions. This frame is meant not only to 
create a secure context for the patient to engage in the difficult process of change, but also allows 
the therapist to interpret deviations from this contract on the patient’s part through the lens of the 
therapeutic relationship. 
TFP has shown evidence of efficacy in two RCT’s. In one, TFP was compared to DBT 
and to supportive psychotherapy, showing effects on several outcome domains that were similar 
(or perhaps superior) to these control treatments. [49] In a second RCT, patients receiving TFP 
showed better outcomes on most BPD-relevant variables than patients receiving psychotherapy 
in the community. [50] However, in a third RCT comparing three years of TFP to three years to 
Schema Therapy (described above), the TFP group did not fare as well as the ST group, in part 
because of higher rates of dropout in TFP. [42] Nevertheless, the low therapist competence 
ratings in the TFP arm raise questions as to how faithfully TFP was delivered in this trial – an 
noteworthy limitation, as conformity to TFP technique is an important predictor of outcome. [51] 
More recent studies have explored mechanisms of change within TFP and identified neural 
correlates of the symptom changes brought about by the treatment. [52,53] 
Adjunctive Treatments 
In addition to the stand-alone, specialty treatments above, several interventions have been 
designed as adjuncts to other treatments. Systems Training for Emotional Predictability and 
Problem Solving (STEPPS) is one such intervention. [54] Like DBT, STEPPS is based in 
cognitive-behavioral principles, considers extreme emotional experience to be a core 
characteristic of BPD, and utilizes group-based skills training. Unlike DBT, however, STEPPS 
also focuses heavily on family systems and psychoeducation, two types of interventions that are 
only incidental to DBT. STEPPS plus treatment-as-usual has shown promising evidence of 
efficacy in comparison to treatment-as-usual in randomized controlled trials, [55,56] and there is 
also promising evidence that STEPPS can be implemented effectively in traditional treatment 
settings. [57] Recent evidence suggests, however, that DBT may be somewhat better than 
STEPPS when it comes to treating overall borderline symptoms. [58]  
A second adjunctive intervention that shows promise in the treatment of BPD is the 
motive-oriented therapeutic relationship (MOTR). This is not a treatment in its own right but 
instead a structured method for managing how the patient’s pathology manifests within the 
relationship with the therapist. Use of the MOTR is intended to obviate the patient’s need to 
enact problematic interpersonal behaviors by identifying and meeting the needs these behaviors 
serve. [59] A randomized trial comparing brief Good Psychiatric Management (GPM; see below) 
with GPM plus MOTR suggested that MOTR yielded additional gains in interpersonal outcomes 
and biased thinking, although reduction in borderline symptoms was similar for both groups. 
[60–62] 
Pragmatic and Psychoeducative Treatments 
In addition to the adjunctive treatment options above, there exist a number of pragmatic 
interventions designed to be used by trainees (e.g., psychiatry residents), case managers, and 
other support specialists. The most prominent of these pragmatic interventions was once called 
“General Psychiatric Management” and is now called Good Psychiatric Management (GPM). 
GPM is a case-management approach based on psychiatric practice guidelines, focusing on 
psychoeducation but also including supportive-psychodynamic and cognitive-behavioral 
psychotherapeutic elements. [63,64] The treatment was developed by John Gunderson and 
manualized [63] to serve as the control treatment for DBT in a randomized trial. [16] Notably, 
this trial is the largest RCT attempted to date, and the authors found no outcome differences 
between DBT and GPM, nor have any emerged at follow-up. [65] Since these early 
developments, GPM has continued to be used as a comparison group for more specific BPD 
treatments, and the encouraging results have prompted calls for GPM to be used as a first-line 
generalist treatment for the disorder. [66,67] 
Finally, Mary Zanarini and colleagues have shown, in two separate trials, that mere 
psychoeducation about BPD (i.e., its clinical characteristics, course, and etiology and available 
treatment options) is better than a no-treatment control, at least on some outcomes. [68,69] The 
superiority of this minimal intervention – in the second trial, delivered via the Internet – may 
speak to the degree to which ignoring the BPD diagnosis, or not sharing it with patients to whom 
it applies, can be harmful, or at least a missed opportunity. Nevertheless, these studies do not 
compare psychoeducation to active treatment comparison conditions, and so it remains to be seen 
whether a well-delivered therapy would be preferable to psychoeducation. 
Does the Kind of Treatment Make a Difference? 
 Given the plurality, and the diversity, of evidence-based psychotherapeutic treatment 
options for BPD, it is scientifically and clinically important to consider the question of whether 
these different psychotherapies work equally well. This is indeed a complex question. 
Randomized controlled trials are undoubtedly the most straightforward way to resolve it, and yet 
there have not been enough head-to-head comparisons of these treatments to provide a definitive 
answer. The extant controlled studies are also extremely varied in terms of treatment dose, 
setting, choice of control group, and other design and sample characteristics, which may 
contribute to the large heterogeneity in effect size among these trials identified by a recent meta-
analysis. [10••] Nonetheless, there is little doubt that the specialized treatments for BPD outlined 
above are more effective, on average, than treatment-as-usual or generic psychological or 
psychiatric care, which on its own shows only small effects. [70•] These bona fide therapies 
should be considered the preferred treatments for BPD based on the available evidence. 
Taken together, head-to-head trials (see Table) do not generally suggest superiority of 
any of the available specialized treatments for BPD relative to one another, despite the results of 
some individual studies suggesting otherwise. In addition, although these treatments operate on 
different theories of BPD and focus on different symptoms of the disorder, none of them is 
uniquely effective in bringing about improvement on the outcome domains they target. Specific 
treatment effects are the exception and not the rule. For instance, TFP improves attachment and 
mentalization, despite the fact that it does not explicitly work to do this, unlike MBT. [71,72] 
Similarly, DBT, not just TFP, shows favorable outcomes for self-concept coherence and 
defensive functioning. [33,73,74] Even though some studies show differences between 
treatments in rates of improvement for different symptoms, these effects are inconsistent from 
trial to trial and sometimes from one measurement to another. For instance, a recent non-
randomized trial found that DBT led to faster reductions in self-harm than MBT, but by the end 
of the study both treatments had achieved the same degree of reduction in this symptom. [33]  
As others have pointed out, the specialized, evidence-based psychotherapies for BPD 
named above – DBT, MBT, ST, and TFP – also have several elements in common. [63,75–77] 
First, they all explicate a coherent model of the disorder within the therapy (despite the lack of 
agreement among treatments about these models themselves). Second, they work within a strong 
treatment frame, which may be necessary to enable the patient to do the difficult work of 
changing his or her behavior. Third, nearly all the treatments are long-term, lasting at least 6 
months. This characteristic may not be strictly necessary, as shorter treatments can also be 
effective, especially at reducing acute symptoms. Randomized trials contrasting long-term and 
short-term versions of both DBT and MBT are also underway. [78,79] Fourth, these treatments 
have a strong focus on the here-and-now rather than on past relationships. Indeed, many 
treatments (such as SFT, TFP, and MBT) use the therapeutic relationship itself to help the patient 
develop more adaptive patterns of relating to others. Finally, each bona fide treatment for BPD 
offers interpersonal continuity in the form of a stable, reliable relationship with a therapist, 
treatment team, and/or therapeutic milieu. The importance of continuity of care for BPD 
outcome should not be overlooked; a fascinating study by Bales and colleagues suggests that 
organizational disruptions may affect the outcome of MBT, for instance. [80•] In sum, it is clear 
that certain specialized psychotherapies for BPD offer an advantage over general community 
treatment. In that respect, the type of treatment does make a difference. There is little compelling 
and consistent evidence, however, that any of these dedicated therapies is superior to any of the 
others, even in treating the specific outcome domains that they attempt to address, and there are 
many possibly important common factors among these treatments. 
Psychotherapeutic Treatment for BPD: What We Still Don’t Know 
Despite the overall evidence for the efficacy and effectiveness of existing 
psychotherapeutic treatment options for BPD, there is still much to be discovered. For example, 
it is not at all clear how to prescribe one of these treatments over another, when a choice is 
available. No matter how consistent the results of a given therapy are for the “average individual 
with BPD,” some patients show little benefit at all, and it is unknown whether these non-
responders would have benefited from an alternative treatment. Similarly, it is not clear whether 
responders to one treatment would have done still better in another. [81] Intriguing initial results 
on this score come from a recent re-analysis of the large RCT by McMain and colleagues 
comparing DBT and GPM. [16] A cross-validated (but within-sample) procedure to identify 
moderators of differential response to these treatments suggested that patients with higher 
severity and impulsivity benefited more from GPM, whereas those with more dependent 
personality traits, childhood emotional abuse, social maladjustment, and higher depression 
severity did better in DBT. [82••] If these results are validated independently, they may point to 
the potential to select optimal treatments for this extremely heterogeneous disorder.  
We also have little idea how long treatment effects within any of these therapies last 
beyond the short term. The longest follow-up assessments to date were 5 years after the 
termination of therapy. [30] Given the often chronic course of BPD, with sustained impairment 
and low functioning the norm even after symptomatic improvement, [83] this lack of knowledge 
about long-term effects is particularly troublesome. Existing treatments for BPD may reliably 
lead to symptom remission, but far less is known about how to facilitate sustained adaptive work 
and relationship functioning. General functioning may improve, [18,32,36,43,49,50,84,85] but 
many treated individuals are still underemployed and lack sufficient stable and meaningful 
romantic and friend relationships at the end of treatment or at follow-up. [30,86] 
Conclusions 
 In sum, there is solid evidence that various specific therapies (including DBT, MBT, ST, 
and TFP) are superior to treatment as usual in the community for Borderline Personality 
Disorder. There are also several adjunctive and minimal/pragmatic treatment options available 
with research support. There is no reliable evidence that any of these treatments is more effective 
than any other, however. In addition, existing treatments have many elements in common that 
may be responsible in part for their effects. Future research will be needed to uncover how 
patient characteristics and treatment parameters affect the outcome of these therapies. 
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Table — Head to Head Comparisons between Evidence-Based Therapies for BPD 
First author Type Treatment groups Outcomes 
Barnicot [33] naturalistic DBT (n = 58) 
MBT (n = 32) 
No differences in clinical 
outcomes at month 12 
Feliu-Soler [87] non-
randomized 
DBT mindfulness (n = 18) 
GPM (n = 17) 
DBT-mindfulness group had 
better depression and 
symptom scores at posttest; 
no difference in emotional 
reactivity 
McMain [16] RCT DBT (n = 90) 
GPM (n = 90) 
No differences in outcomes; 
similarity persists at follow-
up 
Kramer [59] RCT GPM + MOTR (n = 11) 
GPM (n = 14) 
MOTR group showed more 
improvement in 
interpersonal problems; no 
other clinical differences 
Edel [88] non-
randomized 
DBT skills + MBT (n = 
29) 
DBT skills (n = 28) 
No differences in BPD 
symptoms or attachment; 
mixed results on mentalizing 
Kramer [60] RCT GPM + MOTR (n = 42) 
GPM (n = 43) 
MOTR group showed more 
improvement in general 
symptoms, but not BPD 
symptoms or interpersonal 
problems 
Clarkin [49] RCT TFP (n = 23) 
DBT (n = 17) 
No differences in direct 
comparison, although 
treatments had varying 
effects on outcomes pre-post 
Giesen-Bloo [42] RCT ST (n = 45) 
TFP (n = 43) 
ST group showed more 
change in BPD symptoms 
and a composite measure of 
secondary outcomes; no 
differences in quality of life 
Guillén Botella [58] non-
randomized 
DBT (n = 45) 
STEPPS (n = 27) 
DBT group showed more 
improvement in BPD 
behavioral symptoms and 
fear of suicide; no other 
differences 
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